Heroin and cannabis use is declining but new drugs show increase, says EU reportBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3647 (Published 02 June 2014) Cite this as: BMJ 2014;348:g3647
- Rory Watson
The use and availability of heroin in Europe seems to be declining, the Lisbon based European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has said. In its latest annual report, released on 27 May, it noted that the number of reported first time entrants for specialist drug treatment for heroin problems fell from a peak of 59 000 in 2007 to 31 000 in 2012.1
Similarly, although cocaine remained the most commonly used illicit stimulant in Europe, recent data showed that its use was also declining, especially among 15-34 year olds. And after a peak in 2008 notable decreases had occurred …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial